| Patients with composite adverse outcomes (n = 46) | Patients without composite adverse outcomes (n = 127) | P value |
---|---|---|---|
RPC density, % | |||
 Mean | 54.05 ± 3.58 | 55.31 ± 2.92 | 0.020* |
 Peripapillary | 55.13 ± 4.20 | 56.64 ± 3.56 | 0.021* |
RPC capillary density, % | |||
 Mean | 46.18 ± 4.44 | 48.00 ± 3.34 | 0.014* |
 Peripapillary | 47.03 ± 5.30 | 49.17 ± 4.24 | 0.016* |
Macular vessel density, % | |||
 Mean SCP | 49.71 ± 2.96 | 50.78 ± 2.55 | 0.021* |
 SCP-parafovea | 52.30 ± 3.19 | 53.09 ± 2.98 | 0.036* |
 SCP-perifovea | 50.39 ± 3.15 | 51.49 ± 2.79 | 0.029* |
 Mean DCP | 51.32 ± 5.25 | 53.10 ± 5.63 | 0.063 |
 DCP-parafovea | 55.27 ± 4.58 | 56.79 ± 4.83 | 0.067 |
 DCP-perifovea | 52.63 ± 5.78 | 54.48 ± 5.98 | 0.071 |